English

Graymark Healthcare, Inc.

EDGAR

FDNH Quarterly report (10-Q) · filed 2016-09-02

52 filing records in this dataset, filed from 2004-10-12 to 2016-09-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

27.3 million USD

2016 Q2 · USD

Exact inputs and evidence

Revenue: 27342483 USD Source

Operating cash flow

-4.02 million USD

2016 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5292129 USD Source
Operating Cash Flow: -1269377 USD Source

Free cash flow

-4.81 million USD

2016 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5292129 USD Source
Operating Cash Flow: -1269377 USD Source
Capital Expenditure: 2009454 USD Source
Capital Expenditure: 1225379 USD Source

Cash and cash equivalents: 1.1 million USD 2016-06-30 Source
Exact value

1100000 USD
Long-term debt including current maturities: 49.2 million USD 2016-06-30 Source
Exact value

49181644 USD
Shares outstanding: 18.1 million shares 2016-06-30 Source
Exact value

18078337 shares

Reported share-count change

4.81% · 830 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

17248154 shares · 2015-06-30· Source
18078337 shares · 2016-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

131 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Revenue: 32596966 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 126139824 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 94002070 USD · 2015-01-01 – 2015-09-30 Source
Revenue: 38637078 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 27342483 USD · 2016-04-01 – 2016-06-30 Source

Net income

-9.07 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Net income: 514828 USD · 2015-07-01 – 2015-09-30 Source
Net income: 5897352 USD · 2015-01-01 – 2015-12-31 Source
Net income: 4095194 USD · 2015-01-01 – 2015-09-30 Source
Net income: -2382759 USD · 2016-01-01 – 2016-03-31 Source
Net income: -9001548 USD · 2016-04-01 – 2016-06-30 Source

Operating cash flow

509 thousand USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Operating cash flow: 4054794 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: 3256743 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: 9057617 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: 4054794 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -1269377 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -5292129 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -1269377 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

4.53 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Capital expenditure: 1157635 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 720760 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 3236386 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 1157635 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 1225379 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 2009454 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 1225379 USD · 2016-01-01 – 2016-03-31 Source

Free cash flow

-4.02 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Operating cash flow: 4054794 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: 3256743 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: 9057617 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: 4054794 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -1269377 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -5292129 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -1269377 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 1157635 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 720760 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 3236386 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 1157635 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 1225379 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 2009454 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 1225379 USD · 2016-01-01 – 2016-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-09-02.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2015-12-31
operating income: No compatible figures in this window
Net income: 6 of 11 periods available· newest 2015-12-31
Operating cash flow: 6 of 11 periods available· newest 2015-12-31
Capital expenditure: 6 of 11 periods available· newest 2015-12-31
Total assets: 6 of 11 periods available· newest 2015-12-31
Total liabilities: 6 of 11 periods available· newest 2015-12-31
Current assets: 6 of 11 periods available· newest 2015-12-31
Current liabilities: 6 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2015-12-31
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+23.8%

Prior period

USD 101.86 million

2014-01-01 – 2014-12-31
Current period

USD 126.14 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

126139824 − 101858149 = 24281675 USD

101858149 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
126139824 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Year-over-year change in Revenue: 24281675 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 126139824 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#165866 Filing: 000156459016015696 Input fundies:Revenue: 101858149 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#166009 Filing: 000156459016015696
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 7.21 million

Prior period

−USD 1.31 million

2014-01-01 – 2014-12-31
Current period

USD 5.9 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

5897352 − -1312876 = 7210228 USD

-1312876 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
5897352 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Year-over-year change in Net income: 7210228 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 5897352 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#172020 Filing: 000156459016015696 Input fundies:NetIncome: -1312876 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#172171 Filing: 000156459016015696
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+270.3%

Prior period

USD 2.45 million

2014-01-01 – 2014-12-31
Current period

USD 9.06 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

9057617 − 2446053 = 6611564 USD

2446053 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
9057617 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Year-over-year change in Operating cash flow: 6611564 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 9057617 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#191898 Filing: 000156459016015696 Input fundies:OperatingCashFlow: 2446053 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192107 Filing: 000156459016015696
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-33.7%

Prior period

USD 4.88 million

2014-01-01 – 2014-12-31
Current period

USD 3.24 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

3236386 − 4884948 = -1648562 USD

4884948 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
3236386 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Year-over-year change in Capital expenditure: -1648562 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3236386 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192530 Filing: 000156459016015696 Input fundies:CapitalExpenditure: 4884948 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192739 Filing: 000156459016015696
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 126.14 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income USD 5.9 million 4.7% of revenue

Cash

Operating cash flow USD 9.06 million 7.2% of revenue
Capital expenditure USD 3.24 million 2.6% of revenue
Free cash flow Derived USD 5.82 million 4.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Not shown: operating income or net income is not reported.
2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	20521371	Unavailable	Unavailable	Unavailable	-19136006	-4322865 Derived	Source 2010-01-01 – 2010-12-31: 20521371 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -19136006 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -3901578 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 421287 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	17509794	Unavailable	Unavailable	Unavailable	-5894409	-3969877 Derived	Source 2011-01-01 – 2011-12-31: 17509794 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -5894409 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -3799322 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 170555 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	52975503	Unavailable	Unavailable	Unavailable	3728893	-168776 Derived	Source 2012-01-01 – 2012-12-31: 52975503 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 3728893 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 1121875 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 1290651 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	87207659	Unavailable	Unavailable	Unavailable	-19404524	-16282 Derived	Source 2013-01-01 – 2013-12-31: 87207659 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -19404524 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 6351994 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 6368276 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	101858149	Unavailable	Unavailable	Unavailable	-1312876	-2438895 Derived	Source 2014-01-01 – 2014-12-31: 101858149 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -1312876 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 2446053 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 4884948 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	126139824	Unavailable	Unavailable	Unavailable	5897352	5821231 Derived	Source 2015-01-01 – 2015-12-31: 126139824 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 5897352 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 9057617 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 3236386 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 126.1M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Revenue	20521371	Revenue: 20521371 Open source
20112011-12-31	Revenue	17509794	Revenue: 17509794 Open source
20122012-12-31	Revenue	52975503	Revenue: 52975503 Open source
20132013-12-31	Revenue	87207659	Revenue: 87207659 Open source
20142014-12-31	Revenue	101858149	Revenue: 101858149 Open source
20152015-12-31	Revenue	126139824	Revenue: 126139824 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

23.8% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Year over year	No prior comparable period	Revenue: 20521371 Open source
20112011-12-31	Year over year	-14.7%	Revenue: 17509794 Open source Revenue: 20521371 Open source
20122012-12-31	Year over year	202.5%	Revenue: 52975503 Open source Revenue: 17509794 Open source
20132013-12-31	Year over year	64.6%	Revenue: 87207659 Open source Revenue: 52975503 Open source
20142014-12-31	Year over year	16.8%	Revenue: 101858149 Open source Revenue: 87207659 Open source
20152015-12-31	Year over year	23.8%	Revenue: 126139824 Open source Revenue: 101858149 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin 4.7% 2015

Free cash flow margin 4.6% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Operating margin	Not reported	Revenue: 20521371 Open source
2011-12-31	Operating margin	Not reported	Revenue: 17509794 Open source
2012-12-31	Operating margin	Not reported	Revenue: 52975503 Open source
2013-12-31	Operating margin	Not reported	Revenue: 87207659 Open source
2014-12-31	Operating margin	Not reported	Revenue: 101858149 Open source
2015-12-31	Operating margin	Not reported	Revenue: 126139824 Open source
20102010-12-31	Net margin	-93.2%	Net Income: -19136006 Open source Revenue: 20521371 Open source
20112011-12-31	Net margin	-33.7%	Net Income: -5894409 Open source Revenue: 17509794 Open source
20122012-12-31	Net margin	7%	Net Income: 3728893 Open source Revenue: 52975503 Open source
20132013-12-31	Net margin	-22.3%	Net Income: -19404524 Open source Revenue: 87207659 Open source
20142014-12-31	Net margin	-1.3%	Net Income: -1312876 Open source Revenue: 101858149 Open source
20152015-12-31	Net margin	4.7%	Net Income: 5897352 Open source Revenue: 126139824 Open source
20102010-12-31	Free cash flow margin	-21.1%	Revenue: 20521371 Open source Operating Cash Flow: -3901578 Open source Capital Expenditure: 421287 Open source
20112011-12-31	Free cash flow margin	-22.7%	Revenue: 17509794 Open source Operating Cash Flow: -3799322 Open source Capital Expenditure: 170555 Open source
20122012-12-31	Free cash flow margin	-0.3%	Revenue: 52975503 Open source Operating Cash Flow: 1121875 Open source Capital Expenditure: 1290651 Open source
20132013-12-31	Free cash flow margin	-0%	Revenue: 87207659 Open source Operating Cash Flow: 6351994 Open source Capital Expenditure: 6368276 Open source
20142014-12-31	Free cash flow margin	-2.4%	Revenue: 101858149 Open source Operating Cash Flow: 2446053 Open source Capital Expenditure: 4884948 Open source
20152015-12-31	Free cash flow margin	4.6%	Revenue: 126139824 Open source Operating Cash Flow: 9057617 Open source Capital Expenditure: 3236386 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 9.1M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Operating cash flow	-3901578	Operating Cash Flow: -3901578 Open source
20112011-12-31	Operating cash flow	-3799322	Operating Cash Flow: -3799322 Open source
20122012-12-31	Operating cash flow	1121875	Operating Cash Flow: 1121875 Open source
20132013-12-31	Operating cash flow	6351994	Operating Cash Flow: 6351994 Open source
20142014-12-31	Operating cash flow	2446053	Operating Cash Flow: 2446053 Open source
20152015-12-31	Operating cash flow	9057617	Operating Cash Flow: 9057617 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 5.8M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Free cash flow	-4322865	Operating Cash Flow: -3901578 Open source Capital Expenditure: 421287 Open source
20112011-12-31	Free cash flow	-3969877	Operating Cash Flow: -3799322 Open source Capital Expenditure: 170555 Open source
20122012-12-31	Free cash flow	-168776	Operating Cash Flow: 1121875 Open source Capital Expenditure: 1290651 Open source
20132013-12-31	Free cash flow	-16282	Operating Cash Flow: 6351994 Open source Capital Expenditure: 6368276 Open source
20142014-12-31	Free cash flow	-2438895	Operating Cash Flow: 2446053 Open source Capital Expenditure: 4884948 Open source
20152015-12-31	Free cash flow	5821231	Operating Cash Flow: 9057617 Open source Capital Expenditure: 3236386 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

100% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Liabilities / assets	99.4%	Total Liabilities: 28520123 Open source Total Assets: 28692552 Open source
20112011-12-31	Liabilities / assets	82.8%	Total Liabilities: 23160307 Open source Total Assets: 27985330 Open source
20122012-12-31	Liabilities / assets	105.3%	Total Liabilities: 45016508 Open source Total Assets: 42747786 Open source
20132013-12-31	Liabilities / assets	111.9%	Total Liabilities: 61853113 Open source Total Assets: 55274829 Open source
20142014-12-31	Liabilities / assets	112.5%	Total Liabilities: 66818436 Open source Total Assets: 59419631 Open source
20152015-12-31	Liabilities / assets	100%	Total Liabilities: 119618414 Open source Total Assets: 119645629 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.25× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Current assets / current liabilities	0.27×	Current Assets: 7578727 Open source Current Liabilities: 28083273 Open source
20112011-12-31	Current assets / current liabilities	1.67×	Current Assets: 9770590 Open source Current Liabilities: 5839334 Open source
20122012-12-31	Current assets / current liabilities	0.53×	Current Assets: 14778377 Open source Current Liabilities: 27710119 Open source
20132013-12-31	Current assets / current liabilities	0.62×	Current Assets: 24568376 Open source Current Liabilities: 39555603 Open source
20142014-12-31	Current assets / current liabilities	1.03×	Current Assets: 28906885 Open source Current Liabilities: 28154926 Open source
20152015-12-31	Current assets / current liabilities	1.25×	Current Assets: 43435941 Open source Current Liabilities: 34806518 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−USD 19.14 million Exact value Exact value: -19136006 USD 2010-01-01 – 2010-12-31: -19136006 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2010-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: -19136006 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19136006 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312512155027/grmh-20111231.xml#29217 Filing: 000119312512155027 The citation records this snapshot. The page link may show a newer release later.	−USD 3.9 million Exact value Exact value: -3901578 USD 2010-01-01 – 2010-12-31: -3901578 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2010-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: -3901578 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3901578 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312512155027/grmh-20111231.xml#42198 Filing: 000119312512155027 The citation records this snapshot. The page link may show a newer release later.	USD 421,287 Exact value Exact value: 421287 USD 2010-01-01 – 2010-12-31: 421287 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2010-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 421287 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 421287 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312512155027/grmh-20111231.xml#42729 Filing: 000119312512155027 The citation records this snapshot. The page link may show a newer release later.	−USD 4.32 million Calculation and evidence -3901578 − 421287 USD Exact free cash flow: -4322865 USD 2010-01-01 – 2010-12-31: -3901578 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 421287 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2010-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: -4322865 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3901578 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312512155027/grmh-20111231.xml#42198 Filing: 000119312512155027 Input fundies:CapitalExpenditure: 421287 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312512155027/grmh-20111231.xml#42729 Filing: 000119312512155027 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 5.89 million Exact value Exact value: -5894409 USD 2011-01-01 – 2011-12-31: -5894409 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2011-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: -5894409 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5894409 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312513136858/grmh-20121231.xml#130383 Filing: 000119312513136858 The citation records this snapshot. The page link may show a newer release later.	−USD 3.8 million Exact value Exact value: -3799322 USD 2011-01-01 – 2011-12-31: -3799322 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2011-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: -3799322 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3799322 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312513136858/grmh-20121231.xml#118723 Filing: 000119312513136858 The citation records this snapshot. The page link may show a newer release later.	USD 170,555 Exact value Exact value: 170555 USD 2011-01-01 – 2011-12-31: 170555 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2011-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 170555 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 170555 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312513136858/grmh-20121231.xml#120627 Filing: 000119312513136858 The citation records this snapshot. The page link may show a newer release later.	−USD 3.97 million Calculation and evidence -3799322 − 170555 USD Exact free cash flow: -3969877 USD 2011-01-01 – 2011-12-31: -3799322 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 170555 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2011-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: -3969877 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3799322 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312513136858/grmh-20121231.xml#118723 Filing: 000119312513136858 Input fundies:CapitalExpenditure: 170555 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312513136858/grmh-20121231.xml#120627 Filing: 000119312513136858 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 3.73 million Exact value Exact value: 3728893 USD 2012-01-01 – 2012-12-31: 3728893 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2012-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: 3728893 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3728893 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312514124224/fdnh-20131231.xml#1277453 Filing: 000119312514124224 The citation records this snapshot. The page link may show a newer release later.	USD 1.12 million Exact value Exact value: 1121875 USD 2012-01-01 – 2012-12-31: 1121875 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2012-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: 1121875 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1121875 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312514124224/fdnh-20131231.xml#1269043 Filing: 000119312514124224 The citation records this snapshot. The page link may show a newer release later.	USD 1.29 million Exact value Exact value: 1290651 USD 2012-01-01 – 2012-12-31: 1290651 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2012-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 1290651 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1290651 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312514124224/fdnh-20131231.xml#1269789 Filing: 000119312514124224 The citation records this snapshot. The page link may show a newer release later.	−USD 168,776 Calculation and evidence 1121875 − 1290651 USD Exact free cash flow: -168776 USD 2012-01-01 – 2012-12-31: 1121875 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 1290651 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2012-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: -168776 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1121875 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312514124224/fdnh-20131231.xml#1269043 Filing: 000119312514124224 Input fundies:CapitalExpenditure: 1290651 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000119312514124224/fdnh-20131231.xml#1269789 Filing: 000119312514124224 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 19.4 million Exact value Exact value: -19404524 USD 2013-01-01 – 2013-12-31: -19404524 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2013-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: -19404524 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19404524 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459015002148/fdnh-20141231.xml#178308 Filing: 000156459015002148 The citation records this snapshot. The page link may show a newer release later.	USD 6.35 million Exact value Exact value: 6351994 USD 2013-01-01 – 2013-12-31: 6351994 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2013-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: 6351994 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6351994 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459015002148/fdnh-20141231.xml#201895 Filing: 000156459015002148 The citation records this snapshot. The page link may show a newer release later.	USD 6.37 million Exact value Exact value: 6368276 USD 2013-01-01 – 2013-12-31: 6368276 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2013-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 6368276 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6368276 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459015002148/fdnh-20141231.xml#202490 Filing: 000156459015002148 The citation records this snapshot. The page link may show a newer release later.	−USD 16,282 Calculation and evidence 6351994 − 6368276 USD Exact free cash flow: -16282 USD 2013-01-01 – 2013-12-31: 6351994 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 6368276 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2013-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: -16282 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6351994 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459015002148/fdnh-20141231.xml#201895 Filing: 000156459015002148 Input fundies:CapitalExpenditure: 6368276 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459015002148/fdnh-20141231.xml#202490 Filing: 000156459015002148 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 1.31 million Exact value Exact value: -1312876 USD 2014-01-01 – 2014-12-31: -1312876 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2014-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: -1312876 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1312876 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#172171 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	USD 2.45 million Exact value Exact value: 2446053 USD 2014-01-01 – 2014-12-31: 2446053 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2014-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: 2446053 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2446053 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192107 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	USD 4.88 million Exact value Exact value: 4884948 USD 2014-01-01 – 2014-12-31: 4884948 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2014-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 4884948 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4884948 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192739 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	−USD 2.44 million Calculation and evidence 2446053 − 4884948 USD Exact free cash flow: -2438895 USD 2014-01-01 – 2014-12-31: 2446053 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 4884948 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2014-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: -2438895 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2446053 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192107 Filing: 000156459016015696 Input fundies:CapitalExpenditure: 4884948 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192739 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 5.9 million Exact value Exact value: 5897352 USD 2015-01-01 – 2015-12-31: 5897352 USD Inspect Net Income Open source Share or cite Citation for Net Income · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Net Income: 5897352 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5897352 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#172020 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	USD 9.06 million Exact value Exact value: 9057617 USD 2015-01-01 – 2015-12-31: 9057617 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Operating Cash Flow: 9057617 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9057617 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#191898 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	USD 3.24 million Exact value Exact value: 3236386 USD 2015-01-01 – 2015-12-31: 3236386 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Capital Expenditure: 3236386 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3236386 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192530 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.	USD 5.82 million Calculation and evidence 9057617 − 3236386 USD Exact free cash flow: 5821231 USD 2015-01-01 – 2015-12-31: 9057617 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 3236386 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Graymark Healthcare, Inc. · 2015-12-31 Graymark Healthcare, Inc. (edgar:1272597) Free cash flow: 5821231 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:42:39Z Snapshot: dafe680f99bc9b1d0a63374454bb1ca8b74cfb7f63889f4b76580e0c5be4ac12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1272597?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9057617 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#191898 Filing: 000156459016015696 Input fundies:CapitalExpenditure: 3236386 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1272597/000156459016015696/fdnh-20151231.xml#192530 Filing: 000156459016015696 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

52 filings · 1,720 latest values · 1,720 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001272597, 1272597, FDNH, GRMH, edgar:1272597

Also known as FOUNDATION HEALTHCARE, INC., Foundation Healthcare, Inc., GRAYMARK HEALTHCARE, INC., GRAYMARK PRODUCTIONS INC, Graymark Healthcare, Inc.

Graymark Healthcare, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation